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Introduction
Quorum sensing is the ability of micro-organisms to
communicate, via signalling molecules, in order to
coordinate their behaviour. As the discovery of a sub-
stance produced by Vibrio fischeri which induced biolu-
minescence at the early growth stage (Nealson et al.
1970), the quorum sensing phenomenon in bacteria has
been fully studied. However, concerning yeast only few
studies have been performed. In fact, for Candida until
now this regulatory mechanism has only been demonstra-
ted in C. albicans (Hornby et al. 2001; Ramage et al.
2002; Chen et al. 2004), in C. tropicalis (Hazen and Cutler
1979) and recently in C. parapsilosis (Laffey and Butler
2005).
For C. albicans, some compounds were already des-
cribed as quorum sensing molecules (QSM), namely,
tyrosol (Chen et al. 2004) and farnesol (Hornby et al.
2001). Specifically, farnesol was first identified by Horn-
by et al. (2001) as QSM excreted by C. albicans that
was found to inhibit the yeast-to-mycelium conversion
without interference on cell growth. Although the role
of farnesol in the pathogenicity of C. albicans is poorly
understood there is indirect evidence that farnesol
increases the virulence of this fungus (Shea and Del
Poeta 2006). The mechanisms by which farnesol medi-
ates its effect is also not known. Deletion of the histi-
dine kinase CHK1, a component of a stress-adaptation
signalling pathway, was found to protect C. albicans
from the inhibitory effects of farnesol on hyphal trans-
ition and biofilm formation (Kruppa et al. 2004). Shea
and Del Poeta (2006) suggested that farnesol could
influence C. albicans biology in part by modulating the
sterol synthesis pathway.
Currently, the emergence of Non-C. albicans Candida
(NCAC) species is becoming relevant. One of the patho-
genic NCAC species is C. dubliniensis that was recovered
from oral cavities of HIV-infected patients (Sullivan et al.
1995). Despite the lower prevalence of C. dubliniensis in
blood cultures, once an infection has been established this
species can result in increased morbidity (Chan-Tack
2005). This species has been misidentified with C. albicans
for years mainly because of their capacity to form mycelia
(Sullivan et al. 2005).
One of the major determinants of Candida virulence is
its ability to form hyphae or pseudohyphae from unicel-
lular yeast (Yang 2003). Thus, it is important to get
insights into the factors that regulate the morphologic
transition. The correlation between dimorphism and path-
ogenecity suggests that interfering with the morphological
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Abstract
Aims: Cell–cell signalling in Candida albicans is a known phenomenon and
farnesol was identified as a quorum sensing molecule determining the yeast
morphology. The aim of this work was to verify if farnesol had a similar effect
on Candida dubliniensis, highlighting the effect of farnesol on Candida spp.
morphogenesis.
Methods and Results: Two different strains of C. dubliniensis and one of
C. albicans were grown both in RPMI 1640 and in serum in the presence of
absence of farnesol. At 150 lmol l)1 farnesol the growth rate of both Candida
species was not affected. On the contrary, farnesol inhibited hyphae and pseu-
dohyphae formation in C. dubliniensis.
Conclusion: Farnesol seems to mediate cell morphology in both Candida spe-
cies.
Significance and Impact of the Study: The effect of farnesol on C. dubliniensis
morphology was not reported previously.
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switch could be an attractive method for controlling path-
ogenecity. Manipulating dimorphism could force an
opportunistic pathogen to exist only in a form that
should not damage the host (Nickerson et al. 2006). As
farnesol acts preventing the formation of the more patho-
genic C. albicans form, hyphae, it might be useful as a
novel therapeutical antifungal compound for immuno-
compromised patients since it would not upset the nat-
ural resident flora (Hornby et al. 2001). Accordingly, the
main aim of this work was the investigation of the effect
of QSM, namely farnesol, on the morphology of C. dubli-
niensis.
Materials and methods
Strains
Two strains of Candida dubliniensis (CBS 7987 and CBS
7988, from Centraalbureau voor Schimmelcultures,
Germany) and one strain of Candida albicans (CECT
1472, from ‘Coleccio´n Espan˜ola de Cultivos Tipo’, Spain)
were used in this study. For all the assays, these strains
were grown for 24 h in Sabouraud dextrose agar at 37C.
Then, batches of yeast cells were cultured in SDB for 24 h
at 37C and 130 rev min)1. Under these conditions both
Candida species grew in the yeast form.
Media and chemicals
In the current experiments, two different media were used
to favour filamentation: RPMI 1640 medium (Sigma,
Sintra, Portugal) buffered with morpholinepropanesulfonic
acid (MOPS – Sigma) and serum (Foetal Bovine Serum;
Gibco, Barcelona, Spain) 10% in water (Gilfillan et al.
1998). RMPI was used as a common Candida growth
medium and serum was selected for inducing C. dublini-
ensis hyphae formation. Farnesol (trans, trans farnesol –
Sigma) was prepared diluting the solution supplied in
methanol to a stock solution concentration of
600 mmol l)1 and stored at )20C. Working solutions
were prepared in the different filamentation media at final
concentrations of 300, 150, 15 and 1Æ5 lmol l)1.
Effect of farnesol on growth and cell morphology
After the preinoculum in SDB, cells were harvested by
centrifugation (1663 g for 15 min, 4C) and washed twice
with sterile ultrapure water. Cellular density was adjusted
to 1 · 106 cell ml)1 using a Neubauer counting chamber.
These standardized cell suspensions were prepared in the
two filamentation media that were supplemented with
different farnesol concentrations. For each experiment, a
farnesol free control was used.
In order to evaluate the effect of farnesol on growth
rate of batch cultures (grown at 37C and 130 rev min)1),
samples were collected at selected times (2, 4, 6, 8, 10, 12,
14 and 18 h) and cell density was assessed by optical den-
sity (620 nm) in a spectrophotometer [Synergy HT-I
(BIO-TEK, Winooski, VT, USA)].
To evaluate the effect of farnesol on cell morphology,
cell suspensions were grown for 12 h and both macro-
scopic and microscopic evaluations were performed.
Phase contrast microscopic counts were carried out on a
Zeiss Axioskop microscope fitted with 10· and 40· objec-
tives and equipped with a Carl Zeiss AxioCam (HR/MR;
Cambridge, UK). Cellular morphology was characterized
according to Sudbery et al. (2004) into yeast, pseudohy-
phae and hyphae. The quantitative assessment of farnesol
on cellular morphology was performed by calculating the
percentage of hyphae or pseudohyphae inhibition (% I)
based in the number of hyphae or pseudohyphae in the
presence (HPpresfarn) and absence (HPabsfarn) of farnesol
[eqn (1); Chiller et al. 2000].
% I ¼
HPabsfarn HPpresfarn
HPabsfarn
 100 ð1Þ
All experiments were repeated three times with duplicate
samples, and 15 fields per slide were examined.
Statistical analysis
The resulting data were analysed using SPSS (Statistical
Package for the Social Sciences, Chicago, IL, USA). One-
way anova with Bonferroni test was used to compare
either the strains response or the different concentrations
assayed. All tests were performed with a confidence level
of 95%.
Results
Farnesol and Candida growth
As a prerequisite for its quorum sensing activity, farnesol
must not alter the yeast growth rate (Hornby et al. 2001).
The evaluation of the influence of farnesol on cell growth
and growth rate was determined following growth of
C. dubliniensis 7987, C. dubliniensis 7988 and C. albicans
1472 in 150 l mol l)1 of farnesol in RPMI 1640 along
the time and comparing with the control profile (RPMI
1640). Figure 1 represents the growth rate of C. dublini-
ensis 7987 either in the presence or absence of farnesol.
Similar results were obtained for the other strains (data
not shown).
Farnesol concentrations of 150 lmol l)1 do not have
significant inhibitory effect (P < 0Æ05) on C. dubliniensis
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growth and growth rate (Fig. 1). It was also confirmed
that farnesol did not affect C. albicans growth and growth
rate (data not shown) as it was previously reported for
other strains (Hornby et al. 2001). Although C. dublinien-
sis lag phase is higher than for C. albicans, the growth
profile or growth rate of both species is not altered by the
presence of farnesol. For lower farnesol concentrations
(1Æ5 and 15 lmol l)1), there were also no differences
between the growth in presence of farnesol and the con-
trol (data not shown).
Farnesol and Candida morphology in RPMI 1640
To evaluate the activity of farnesol on Candida morphol-
ogy, samples from batch cultures with and without farne-
sol (150 lmol l)1) treatment were collected at stationary
phase (12 h) and observed under phase contrast micros-
copy (Fig. 2).
Both C. dubliniensis and C. albicans grow in yeast
form in SDB (the medium used for the preinoculum;
Fig. 2i). At low cell population density (1 · 106
cells ml)1), C. albicans formed true hyphae in RPMI
1640, as it was expected (Fig. 2c-ii), while C. dublinien-
sis strains grow as pseudohyphae in this medium
(Figs 2a-ii,b-ii). However, if any of the cells suspensions
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Figure 1 Growth curves of C. dubliniensis 7987 grown in RPMI
1640 (—-) and in RPMI 1640 supplemented with 150 lmol l)1
farnesol (- - - -).
(i) (ii) (iii)
(a)
(b)
(c)
Figure 2 Phase contrast microscopy observation of (a) C. dubliniensis 7987, (b) C. dubliniensis 7988 and (c) C. albicans 1472 grown for 12 h in
SDB (i), in RPMI 1640 (ii) and in RPMI 1640 supplemented with 150 lmol l)1 of farnesol (iii). The bar in the images corresponds to 50 lm.
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is treated with 150 lmol l)1 farnesol (Fig. 2iii) occur
the inhibition of the filamentous form with high pre-
valence of blastospores.
According to other reports (Kim et al. 2002; Ramage
et al. 2002) it would be expected that in C. albicans dif-
ferent farnesol concentrations triggered different effects
on cellular morphology. Therefore, to confirm and quan-
titatively rank the sensitivity of Candida yeast cells to
farnesol, cells suspensions were cultured for 12 h in dif-
ferent concentrations of farnesol and the percentage of
inhibition of hyphae (Table 1) and pseudohyphae (Fig. 3)
formation was determined.
Figure 3 and Table 1 show that farnesol concentrations
assayed are effective on both C. albicans and C. dublinien-
sis morphology inhibiting the formation of hyphae and
pseudohyphae, respectively. For all the concentrations tes-
ted, it can be noticed that no significant differences were
observed between the percentage of inhibition of hyphae/
pseudohyphae formation among the strains (P > 0Æ005).
However, for all the strains, cells treated with the lower
farnesol concentrations (1Æ5 and 15 lmol l)1) presented
significant differences (P < 0Æ05) when compared with
cells treated with the highest farnesol concentration
(150 lmol l)1), showing some weak dose dependence. It
is interesting to note that even in the presence of
1Æ5 lmol l)1 farnesol the percentage of inhibition of
either hyphae or pseudohyphae was higher than 50%.
For the higher farnesol dosage (150 lmol l)1) 90% of
inhibition was achieved. It can also be referred that
300 lmol l)1 of farnesol inhibits the complete formation
of hyphae and pseudohyphae without exhibiting any inhi-
bition effect upon cellular growth (data not shown).
Although both species grow with different morphologies
in RPMI 1640, farnesol blocks the yeast to hyphae/pseu-
dohyphae conversion in all strains.
Farnesol and Candida morphology in serum
The effectiveness of farnesol in inhibiting hyphae forma-
tion on C. dubliniensis was also assessed in a germ tube
inducing medium, Foetal Bovine Serum (Gilfillan et al.
1998; Fig. 4). The results showed that C. dubliniensis form
true hyphae in the presence of 10% serum (Fig. 4a). On
the contrary, the total absence of hyphae in cells treated
with 150 lmol l)1 farnesol (Fig. 4b) proves the farnesol
effectiveness on C. dubliniensis morphology.
In fact, in the conditions tested for both strains of
C. dubliniensis 100% inhibition was achieved not only by
300 lmol l)1 of farnesol but also with 150 lmol l)1.
Interestingly, for the strain of C. albicans studied the dose
of farnesol that inhibits 100% of hyphae formation is
higher than for C. dubliniensis, being even higher than
400 lmol l)1 (results not shown). The results show that
in C. dubliniensis farnesol not only inhibits pseudohyphae
(in RPMI 1640) but also suppresses hyphae formation.
Discussion
Farnesol was found to be excreted by C. albicans (Hornby
et al. 2001) and to act as a QSM regulating its morphol-
ogy. To the authors knowledge, there are no studies con-
cerning the effect of this molecule on C. dubliniensis
growth and morphology, which seems important once
this species is closely related to C. albicans and hyphae
Table 1 Percentage of hyphae inhibition in C. albicans 1472, when
grown for 12 h in the presence of 1Æ5, 15 and 150 lmol l)1 of farne-
sol in RPMI 1640
Farnesol concentration (lmol l)1)
1Æ5 15 150
% hyphae inhibition
(average ± SD) 73Æ5 ± 16Æ8 82Æ8 ± 10Æ5 97Æ4 ± 3Æ8
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Figure 3 Percentage of pseudohyphae
inhibition in C. dubliniensis 7987 ( ) and
C. dubliniensis 7988 (n), when grown for
12 h in the presence of 1Æ5, 15 and
150 lmol l)1 of farnesol in RPMI 1640.
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formation is an important virulence factor. The results
presented herein show that farnesol affects C. dubliniensis
morphology, blocking not only hyphae but also pseu-
dohyphae development. The effect of (E,E)-farnesol was
evaluated concerning cellular and filamentous growth.
This farnesol isomer was chosen according to the results
reported in the literature, which show that it is the most
active isomer against the C. albicans morphological trans-
ition (Shchepin et al. 2003).
According to the results obtained, the growth of both
C. dubliniensis strains was not inhibited by the presence
of 150 lmol l)1 farnesol (Fig. 1). Moreover, the results
also corroborate, what was already found by other
authors (Hornby et al. 2001; Ramage et al. 2002), that
farnesol does not affect C. albicans growth rate. Thus, in
terms of growth rate, farnesol does not have any effect
over both species, in the concentrations assayed. How-
ever, Kim et al. (2002) showed a growth inhibition of
35% for C. albicans grown in the presence of farnesol
450 lmol l)1. In this sense, it cannot be excluded that for
C. dubliniensis similar effect could be observed for higher
farnesol concentrations. However, the mechanism
involved in this growth inhibition is not yet well known.
Nevertheless, farnesol concentrations of 25 lmol l)1 and
10 lmol l)1 applied externally to Saccharomyces cerevisiae
(Machida et al. 1998) and Aspergillus nidulans (Semighini
et al. 2005), respectively, led to growth inhibition through
induced intracellular reactive oxygen species production.
Altogether, these results show an antagonistic effect of
farnesol among different fungi species suggesting that,
farnesol may contribute to the success of Candida spp. as
pathogen.
Considering filamentous growth, different concentra-
tions of farnesol supplemented to both RPMI 1640 and
10% serum media were used in order to verify the dose
effect on morphology inhibition. In RPMI 1640, the
behaviour of the different strains tested was similar,
showing an inhibition of hyphae/pseudohyphae c. 90%
for the higher farnesol concentrations and higher than
50% for the lower farnesol concentration assayed
(1Æ5 lmol l)1; Fig. 3 and Table 1), indicating some dose
dependent effect. The lower farnesol concentration
(i)
(ii)
(a) (b)
Figure 4 Phase contrast microscopy observation of (i) C. dubliniensis 7987 and (ii) C. dubliniensis 7988 grown in 10% serum in the absence (a)
or presence (b) of farnesol 150 lmol l)1 in 1 h batch cultures. The bar in the images corresponds to 50 lm.
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to achieve 50% inhibition of hyphae/pseudohyphae
formation may have a relevant physiological effect since
several C. albicans strains grown for 24 h produce farne-
sol at 2–4 lmol l)1 (Hornby and Nickerson 2004). To
date, there are no reports on the literature concerning the
production of farnesol by C. dubliniensis planktonic or
biofilm growing cells. However, it has been shown in
competition growth assays performed with planktonic
and biofilm cells that C. albicans had competitive advant-
age over C. dubliniensis (Kirkpatrick et al. 2000). Whether
this interspecies interaction is mediated by an environ-
mental factor such as farnesol would be worth to investi-
gate.
In RPMI 1640, a medium where C. albicans grows in
hyphal form, C. dubliniensis formed pseudohyphae
(Fig. 2ii), which could be observed after 2 h of growth
(data not shown). On account of this, a germ tube for-
mation medium was used to evaluate the effect of farne-
sol on C. dubliniensis hyphae development. The selected
medium was serum based on studies of Sudbery et al.
(2004). In fact, the results in serum (Fig. 4), were in
agreement with the ones obtained in RPMI 1640 (Fig. 3),
with farnesol inhibiting yeast to hyphae transition in
C. dubliniensis strains. As suggested by Mosel et al. (2005)
the higher concentrations of farnesol needed to suppress
hyphae formation in serum are due to nonspecific lipid
binding abilities of the albumins in that medium. More-
over, the results presented show that for the same farnesol
concentrations hyphae inhibition in C. dubliniensis strains
was more effective than for C. albicans.
The role of farnesol in the pathogenicity of Candida
spp. is not well understood. Although the initial studies
with farnesol, as QSM, pointed out its use as a therapeu-
tic agent, recent reports show that fluconazole pretreated
C. albicans cells, producing significantly higher levels of
farnesol, presented enhanced pathogenicity (Navarathna
et al. 2005). Interestingly, it has been described that
C. dubliniensis exposed to fluconazole present higher
adherence to epithelial cells than yeast cells that had not
been exposed to the drug (Zepelin et al. 2002). Consider-
ing all these findings it should be evaluated if exogenous
and endogenous sources of farnesol, plays or not a pivotal
role in the adherence of C. dubliniensis cells contributing
to its pathogenicity.
Farnesol has been shown for the first time to inhibit
the formation of both pseudohyphae and hyphae in two
strains of C. dubliniensis. Although C. dubliniensis has the
capacity to produce hyphae, several studies (Sullivan et al.
2005) pointed out that the control of morphogenesis in
C. albicans and C. dubliniensis may have different regula-
tion pathways. In spite of these observations, the results
presented herein show that farnesol controls the morpho-
genesis of C. dubliniensis in a similar way to that of
C. albicans. In fact, quorum sensing mediated throughout
farnesol seems to be a phenomenon used by Candida spp.
to regulate its morphogenesis. However, the role of farne-
sol in C. dubliniensis virulence and interaction with other
micro-organisms, as well as the molecular mechanism
and signal pathways involved in the action of farnesol
should be further understood.
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